China in the Fast Lane - How to play and win in the world's hottest emerging market
Watch this webcast in which Pei Li Teh and Wan Ling Neo explore China's evolving healthcare environment. In this webcast they highlight the key changes affecting pharma and demonstrate how to build the market understanding required to launch a brand effectively in this exciting region.
New hopes for Mexico
What will be the future of healthcare under the country's new administration?
In December 2018 the new Mexican President, Andres Manuel Lopez Obrador came into office after a landslide victory of over 65% of the votes (more than 30 billion voters). López Obrador was a former Mexico City mayor and has been a major political figure for over twenty years. Widely regarded as both a populist and nationalist, his ideology is to end poverty and improve the lives of his people by fighting corruption and increasing austerity within the government.
Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?
China has long been a magnet for pharmaceutical multinationals looking to offset flattening growth in established markets
It offers rapid economic development, a population of around 1.4 billion with limited access to cutting-edge medicine, and changing lifestyles that have raised health expectations. Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities for innovative drugs alongside low-cost generics.
Experience conducting research in South East Asia
Our emerging markets team has considerable expertise conducting research in South East Asia, with our Asia headquarters located in Singapore, we can support your market research needs. We have conducted over 150 healthcare market research projects across South East Asia covering a wide variety of research objectives and over 25 therapy areas, for both local and international organisations.
Intellus Worldwide Summit round up 2019
This May, Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director exhibited at and attended the Intellus Worldwide Summit in Philadelphia.